A nusinersen sodium (12mg 5ml/1vail) 2 vials,b satralizumab (genetical recombi nation) (120mg 1ml/1

Tender Notice

Tender Detail
A nusinersen sodium (12mg 5ml/1vail) 2 vials,b satralizumab (genetical recombi nation) (120mg 1ml/1syringe) 47 syrin ges,c ravulizumab (genetical recombination) (300mg 3ml/1vial) 42 vials,d andexanet alfa (genetical recombination) (200mg/1vial) 82
Tendering Authority
Tender Category
Other
Publish Date
17 Apr 2025
Deadline
06 Jun 2025
Country
Japan
TenderNews Ref. No.
2062916250417-0
Document Fees
Refer Document.
EMD
Refer Document.
Tender Value
Refer Document.
« Previous Tender      Next Tender »

Some of Our Valuable Clients